Vanguard Global Advisers’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
6CM
Vanguard Global Advisers's CDLX Position: Q3 2026 in Review
Vanguard Global Advisers held its Cardlytics (CDLX) position steady in Q3 2026 at 1,532 shares worth $4.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3603.
Vanguard Global Advisers first reported a position in CDLX in Q1 2026 and has held it in 3 quarters since. The position peaked at $16.1K in Q1 2026. 40 funds tracked by Wall St. Rank hold CDLX as of Q3 2026.
- Vanguard Global Advisers held 1,532 shares of Cardlytics worth $4.5K as of Q3 2026.
- Vanguard Global Advisers left its Cardlytics share count unchanged in Q3 2026.
- Cardlytics made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #3603 holding.
- Vanguard Global Advisers first reported a position in Cardlytics in Q1 2026 and has held it in 3 quarters since.
- Vanguard Global Advisers's Cardlytics position peaked at $16.1K in Q1 2026.
- 40 funds tracked by Wall St. Rank held Cardlytics as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.